Introduction: Monochorionic-diamniotic (MCDA) twin pregnancies are high risk, due to twin-to-twin transfusion syndrome (TTTS), twin anaemia polycythaemia sequence (TAPS) and intrauterine growth restriction (IUGR). There is limited evidence to guide ultrasound surveillance protocols. Using a retrospective cohort, we aimed to provide insight into the optimal interval of ultrasound surveillance. Methods: Retrospective cohort of women with MCDA pregnancies who received antenatal care at Monash Medical Centre (January 2011-October 2014). We reviewed all ultrasounds from ≥15 weeks' gestation and collected perinatal outcomes. Results: A total of 162 women with MCDA pregnancies attended our care. Six women were excluded due to late referral. Of the remaining 156, 55% were uncomplicated. TTTS, TAPS, IUGR and fetal demise in utero occurred in 9%, 1%, 31% and 2%, respectively. Median interval between the last ultrasound and TTTS diagnosis was 3.1 weeks (IQR 0.8-5.8). There was a trend towards a longer interval for cases with advanced TTTS compared to early TTTS. Interval between ultrasound scans was longer in cases with unexplained fetal demise in utero and advanced TTTS than early TTTS [3.4 weeks (IQR 2.0-6.9) vs. 0.9 weeks (IQR 0.4-3.7); p < 0.05]. Discussion: Our observations support current recommendations for fortnightly ultrasound surveillance in MCDA pregnancies from 16 weeks' gestation and suggest that longer intervals may be associated with poorer outcomes.

Keywords:
Fetal growth, Pregnancy complication, Ultrasonography, Monochorionic twin, Multiple gestation, Perinatal mortality
1.
Gratacos E, Ortiz JU, Martinez JM: A systematic approach to the differential diagnosis and management of the complications of monochorionic twin pregnancies. Fetal Diagn Ther 2012;32:145-155.
2.
Lewi L, Gucciardo L, Van Mieghem T, de Koninck P, Beck V, Medek H, Van Schoubroeck D, Devlieger R, De Catte L, Deprest J: Monochorionic diamniotic twin pregnancies: natural history and risk stratification. Fetal Diagn Ther 2010;27:121-133.
3.
Bahtiyar MO, Emery SP, Dashe JS, Wilkins-Haug LE, Johnson A, Paek BW, Moon-Grady AJ, Skupski DW, O'Brien BM, Harman CR, Simpson LL; North American Fetal Therapy Network: The North American Fetal Therapy Network consensus statement: prenatal surveillance of uncomplicated monochorionic gestations. Obstet Gynecol 2015;125:118-123.
4.
Lopriore E, Middeldorp JM, Oepkes D, Kanhai HH, Walther FJ, Vandenbussche FP: Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligo-polyhydramnios sequence. Placenta 2007;28:47-51.
5.
Barigye O, Pasquini L, Galea P, Chambers H, Chappell L, Fisk NM: High risk of unexpected late fetal death in monochorionic twins despite intensive ultrasound surveillance: a cohort study. PLoS medicine 2005;2:e172.
6.
National Institute for Health and Care Excellence: Multiple Pregnancy: The Management of Twin and Triplet Pregnancies in the Antenatal Period. 2011.
7.
Royal Australian College of Obstetrics and Gynecology: Management of Monochorionic Twin Pregnancy. 2011.
8.
Royal College of Obstetrics and Gynecology: Management of Monochorionic Twin Pregnancies. 2008.
9.
The Society of Obstetricians and Gynaecologists of Canada: Ultrasound in Twin Pregnancies. 2011.
10.
Sueters M, Middeldorp JM, Lopriore E, Oepkes D, Kanhai HH, Vandenbussche FP: Timely diagnosis of twin-to-twin transfusion syndrome in monochorionic twin pregnancies by biweekly sonography combined with patient instruction to report onset of symptoms. Ultrasound Obstet Gynecol 2006;28:659-664.
11.
Thorson HL, Ramaeker DM, Emery SP: Optimal interval for ultrasound surveillance in monochorionic twin gestations. Obstet Gynecol 2011;117:131-135.
12.
Davies-Tuck M, Yim C, Knight M, Hodges R, Doery JCG, Wallace E: Vitamin D testing in pregnancy: does one size fit all? Aust NZ J Obstet Gynecol 2015;55:149-155.
13.
Hadlock FP, Harris RB, Sharman RS, Deter RL, Park SK: Estimation of fetal weight with the use of head, body and femur measurements - a prospective study. Am J Obstet Gynecol 1985;151:333-337.
14.
Quintero RA, Morales WJ, Allen HM, Bornick PW, Johnson PK, Kruger M: Staging of twin-twin transfusion syndrome. J Perinatol 1999;19:550-555.
15.
Blickstein I, Kalish RB: Birthweight discordance in multiple pregnancy. Twin Res 2003;6:526-531.
16.
Gratacos E, Lewi L, Munoz B, Acosta-Rojas R, Hernandez-Andrade E, Martinez J, Carreras E, Deprest J: A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin. Ultrasound Obstet Gynecol 2007;30:28-34.
17.
Kagan KO, Gazzoni A, Sepulveda-Gonzales G, Sotiriadis A, Nicolaides KH: Discordance in nuchal translucency thickness in the prediction of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 2007;29:527-532.
18.
Lewi L, Lewi P, Diemert A, Jani J, Gucciardo L, Van Mieghem T, Doné E, Gratacós E, Huber A, Hecher K, Deprest J: The role of ultrasound examination in the first trimester and at 16 weeks' gestation to predict fetal complications in monochorionic diamniotic twin pregnancies. Am J Obstet Gynecol 2008;199:493.e1-493.e7.
19.
Baraa Allaf M, Vintzileos AM, Chavel MR, Wax JA, Ravangard SF, Figueroa R, Borgida A, Shamshirsaz A, Markenson G, Davis S, Habenicht R, Haeri S, Ozhand A, Johnson J, Sangi-Haghpeykar H, Spiel M, Ruano R, Meyer M, Belfort MA, Ogburn P, Campbell WA, Shamshirsaz AA: First-trimester sonographic prediction of obstetric and neonatal outcomes in monochorionic diamniotic twin pregnancies. J Ultrasound Med 2014;33:135-140.
20.
Corcoran S, Breathnach F, Burke G, McAullife F, Geary M, Daly S, Higgins J, Hunter A, Morrison JJ, Higgins S, Mahony R, Dicker P, Tully E, Malone FD: Dichorionic twin ultrasound surveillance: sonography every 4 weeks significantly underperforms sonography every 2 weeks: results of the Prospective Multicenter ESPRiT Study. Am J Obstet Gynecol 2015;213:551.e1-551.e5.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.